For the past 18 months, Irish medtech start-up Deciphex has been working to open its own pathological testing lab in the UK. Deciphex has already proven to be very popular in the UK by providing access to additional pathologists to an overstretched NHS. On Tuesday, the company secured a critical approval from the UK Accreditation Service (Ukas) to push further into the market by conducting its own pathological tests – as opposed to just reviewing them. “I think it’s transformative on multiple levels,” Deciphex CEO Donal O’Shea told The Currency, as the company announced the opening of a new test…

Want to continue reading?

Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.

Subscribe

Cancel at any time.

Are you already a member? .